By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific today said that it has acquired Trek Diagnostic Systems from Magellan Biosciences for an undisclosed amount.

Trek makes blood culture, microorganism identification, and antibiotic-susceptibility testing products for the pharmaceutical and clinical lab markets. The firm is based near Cleveland, has 150 employees, and had full-year 2010 revenues of $34 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The New York Times reports that as China invests in science, it also is dealing with research fraud.

In PLOS this week: transcriptome study of a cold-tolerant plant, deep sequencing of clinical influenza A samples, and more.

The Atlantic writes that retrotransposons like BovB have proliferated in a number of genomes.

Researchers have sequenced the genome of a man who lived in China some 40,000 years ago, according to UPI.